Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05622903 · ClinicalTrials.gov registry record · NA
Effect of Cash Benefits on Health Care Utilization
A NA study, sponsored by Harvard Medical School (HMS and HSDM).
- Completed
- Registry status
- NA
- Development phase
- 3,615
- Enrollment target
NCT05622903 is a NA study that has completed, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 3,615 participants.
The verdict
NCT05622903, a NA study, has completed, sponsored by Harvard Medical School (HMS and HSDM).
- COMPLETED
- Registry status
- NA
- Development phase
- 3,615 participants
- Enrollment target
Study Summary
Using data from the Chelsea Eats program, we propose to study a randomized controlled trial in which the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months during the first two years of the COVID-19 pandemic. We will analyze the impact of the cash benefit on health care utilization and health.
Interventions
- OTHER Cash Benefit
- OTHER No Cash Benefit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,615 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05622903
The ClinicalTrials.gov registry entry for NCT05622903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,615 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Medical School (HMS and HSDM), which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cash Benefit is the first listed.
NCT05622903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05622903 about?
NCT05622903 is a clinical study titled "Effect of Cash Benefits on Health Care Utilization". Using data from the Chelsea Eats program, we propose to study a randomized controlled trial in which the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months during the first two years of the COVID-19 pandemic. We will analyze the impact of the cash...
What is the current status of trial NCT05622903?
This trial is currently completed. It is a NA study. The enrollment target is 3,615 participants. The study started on 2020-07-27. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT05622903?
The interventions under investigation include: Cash Benefit (OTHER), No Cash Benefit (OTHER).
Who is sponsoring clinical trial NCT05622903?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.